PhRMA

NOVEMBER 9, 2022

The June decision by WTO members to waive commitments to protect intellectual property (IP) for COVID-19 vaccines under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was a political and ineffective measure that does not address the true barriers to vaccine equity. Now, some are pushing to extend this harmful waiver to COVID-19 treatments, even though production exceeds demand for treatments, including for the most effective antivirals and monoclonal antibodies.

Vaccines 289

Vaccines 289

Drug Topics

NOVEMBER 9, 2022

Many diabetes patients are rationing supplies, putting off purchasing them, or completely forgoing them because of costs.

201

201

Pharmacy Times

NOVEMBER 9, 2022

The American Heart Association issued a dietary guidance in 2021 suggesting that adults consume a variety of fruits and vegetables, choose whole grains instead of refined grains, eat healthy protein sources and lean cuts of meat, and substitute nonfat and low-fat dairy products for full-fat versions, among other measures.

139

139

Drug Topics

NOVEMBER 9, 2022

As a health plan worked to boost medication adherence among members, it made a startling discovery.

187

187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 9, 2022

Research indicates that administering vitamin C to dendritic cells produces more consistent activation of genes involved in the immune response.

Immunization 137

Immunization 137

Drug Topics

NOVEMBER 9, 2022

Learn more about the difference between CBD and THC—and why it matters.

187

187

Pharmaceutical Technology

NOVEMBER 9, 2022

Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. On November 2, the Institute for Clinical and Economic Review (ICER) released its updated evidence aimed at measuring the clinical effectiveness and cost of the two haemophilia gene therapies.

FDA 111

FDA 111

Pharmacy Times

NOVEMBER 9, 2022

Analysis includes an overview of the epidemiology, expression, and treatment of human papillomavirus infections during both gestation and childhood.

123

123

Pharmaceutical Technology

NOVEMBER 9, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer and BioNTech’s bivalent Covid-19 booster vaccine that targets the SARS-CoV-2 virus’ original strain and the Omicron BA.4 and BA.5 sub-variants. Indicated for usage as a booster in people aged 12 years and older, the modified vaccine is the second bivalent shot of the companies to obtain approval in the region.

Vaccines 105

Vaccines Dosage 105

Pharmacy Times

NOVEMBER 9, 2022

Study results revealed a significant correlation between perceived quality of pharmacy structure, pharmacy engagement, and customer devotion.

121

121

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

NOVEMBER 9, 2022

Thinking carefully about how data are collected is the first step improving health outcomes.

123

123

Pharmacy Times

NOVEMBER 9, 2022

Dr McHayleh provides an overview of HR+/HER2- breast cancer treatment strategies and practices.

138

138

STAT

NOVEMBER 9, 2022

To protect this child from the same genetic disease that killed two older siblings, treating her as soon as she was born might only work so well, the doctors knew. So they dialed back the therapeutic clock, delivering the medication to her as a fetus. Now 16 months old, Ayla appears totally healthy. She still requires weekly doses of the medication, an enzyme that she can’t produce on her own, but she has no symptoms of the condition she inherited, the most serious form of the rare Pompe

101

101

Fierce Healthcare

NOVEMBER 9, 2022

Experts urge polio vaccination to ward off any major resurgence. fdiamond. Wed, 11/09/2022 - 15:06.

Vaccines 135

Vaccines 135

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

NOVEMBER 9, 2022

29-year-old biotech founder Joe Landolina is hoping to capitalize on major possibilities in the human health market through his startup Cresolin and just inked a research partnership with Walter Reed.

98

98

The Checkup by Singlecare

NOVEMBER 9, 2022

You might have been prescribed hydroxyzine because you had an allergic reaction—or even to manage anxiety symptoms. One of its side effects is drowsiness. Naturally, you are wondering, “Can I drink coffee while taking hydroxyzine?” It’s a common question, especially if you need to take this medication during daytime hours. “Hydroxyzine is an interesting drug because it can be prescribed for a variety of different uses,” says Frank J.

98

98

PharmaVoice

NOVEMBER 9, 2022

Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Not every leader makes it their mission to go where the fire.

98

98

Pharmacy Times

NOVEMBER 9, 2022

These show promise as markers to help identify individuals with the conditions and develop targeted therapeutic options.

114

114

Fierce Healthcare

NOVEMBER 9, 2022

Providers urge Biden to tackle 'gridlocked' hospital EDs and life-threatening care delays. dmuoio. Wed, 11/09/2022 - 13:55.

Hospitals 119

Hospitals 119

STAT

NOVEMBER 9, 2022

An FDA advisory panel voted 5-to-8 to recommend rejecting a new drug for patients hospitalized with Covid-19, ruling that a glimmer of potential life-saving benefit couldn’t make up for a long list of questions around the company’s main trial.  The debate centered around sabizabulin, a molecule originally put in development for cancer but repurposed during the pandemic.

FDA 97

FDA Hospitals 97

Pharmacy Times

NOVEMBER 9, 2022

Shayla Smith was the recipient of the 2022 Next Generation Pharmacist – Technician of the Year award.

123

123

STAT

NOVEMBER 9, 2022

Ask most Americans to name a victim of polio and they’ll say President Franklin Delano Roosevelt. Ask me the name of a polio victim and I would offer two: my father’s older sister and his youngest brother. My dad’s sister was a medical student in India when she died of polio in 1950. She contracted it from their younger brother, my uncle, who was five years old at the time and became permanently paralyzed in his right leg.

Vaccines 97

Vaccines 97

pharmaphorum

NOVEMBER 9, 2022

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable levels of the virus compared to an earlier readout. In the latest results from the 457-patient B-Clear study, published in the New England Journal of Medicine, bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the

96

96

Pharmig

NOVEMBER 9, 2022

Over the past 30 years, Pharmig’s annual UK conference has been a highlight for microbiology professionals and enthusiasts from across the country and beyond. The post Pharmig’s 30th Anniversary Conference appeared first on Pharmig.

93

93

pharmaphorum

NOVEMBER 9, 2022

It goes without saying that The Economist’s 8th Annual World Cancer Series congress was well-attended in Brussels this week, the unofficial capital of the European Union. Held at the Marriott Hotel Grand Place, the event’s sponsors included diamond sponsor AstraZeneca, platinum sponsors MSD and Takeda, and gold sponsor Janssen, as well as silver sponsors Guardant and Pfizer, and associate sponsor onko.

Insurance 93

Insurance 93

Drug Topics

NOVEMBER 9, 2022

Inland Pharmacy is using pharmacy automation to put more emphasis on patient care.

Patient Care 112

Patient Care 112

STAT

NOVEMBER 9, 2022

Clovis Oncology, a maker of cancer drugs, warned Wednesday that it will likely file for bankruptcy protection due to dwindling sales of its sole product, mounting financial losses, and a crushing debt load. Based on its current operating plan, Clovis does not have the resources to remain financially solvent beyond January 2023, the company said in its quarterly filing with the Securities and Exchange Commission.

90

90

Fierce Healthcare

NOVEMBER 9, 2022

Industry Voices—Telehealth is dead. The era of hybrid care has arrived. hlandi. Wed, 11/09/2022 - 11:43.

119

119

pharmaphorum

NOVEMBER 9, 2022

If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today. In fact, in the 1950s and 1960s, life expectancy for the disease was around just 30 years.* However, medical innovations over recent decades have significantly improved the length and quality of life for people with the condition, transforming what was once a devastating disease into a condition that can be mostly well-managed.

88

88

STAT

NOVEMBER 9, 2022

Shares of Merrimack Pharmaceuticals, a shuttered drug company with no employees or any active research programs, more than doubled Wednesday because of a $225 million windfall that it will receive due to the success of a treatment for pancreatic cancer. The approved cancer drug, called Onivyde, was once owned by Merrimack, but was sold in 2017 to the French drugmaker Ipsen.

88

88

Fierce Healthcare

NOVEMBER 9, 2022

CMS' disproportionate share hospital payment formula structurally disadvantages Black communities, study finds. dmuoio. Wed, 11/09/2022 - 17:17.

Hospitals 95

Hospitals 95

STAT

NOVEMBER 9, 2022

The idea that the narrowing gap between Covid-19 deaths among white Americans and Americans of color represents a racial equity success story is being bandied about. Not so fast, says Nathan T. Chomilo, a pediatrician and internist at the University of Minnesota Medical School. To be sure, it’s worth celebrating the tenacity of community champions who relentlessly fought for equitable access to vaccines and the subsequent reduction in deaths among Black and Hispanic people.

Medical Schools 85

Medical Schools Vaccines 85

Fierce Healthcare

NOVEMBER 9, 2022

LAN report: Medicare Advantage plans increased spending on 2-sided risk models in 2021. rking. Wed, 11/09/2022 - 15:13.

105

105

European Pharmaceutical Review

NOVEMBER 9, 2022

GSK has announced study results from its Phase IIb trial ( NCT04449029 ) of bepirovirsen for chronic hepatitis B (CHB), indicating that the antisense oligonucleotide therapy could help treat CHB independently or in combination with nucleoside/nucleotide analogues (NAs). Bepirovirsen demonstrated clearance of hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA long term, in patients on concurrent NA and those not-on-NA therapy.

82

82